🎙️ In this episode of the Not Just NE Cancer podcast, Neuroendocrine Cancer UK CEO and Co-Founder, Cathy Bouvier Ellis sits down with Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim.

Together, they explore:

• Common misconceptions about the pharmaceutical industry
• How patient organisations and the industry can work collaboratively
• How effective these collaborations can be

Tanya also highlights a current clinical trial led by Boehringer Ingelheim for Extrapulmonary Neuroendocrine Carcinoma (EP-NEC). You can find more information about this trial here:

 🔗 Boehringer Ingelheim – EP-NEC Clinical Trial

To learn more about ongoing neuroendocrine cancer research, visit our website:
 🔗 Neuroendocrine Cancer UK – Research

Support the show